Figure 4From: BRCAA1 monoclonal antibody conjugated fluorescent magnetic nanoparticles for in vivo targeted magnetofluorescent imaging of gastric cancerFACSCalibur Flow cytometer analysis of MGC803 labeled with FMNPs and FMNPs-BRCAA1. A: the MGC803 treated with 50 μg/mL of FMNPs for 24 h exhibited 25.23% cell were labeled with FMNPs. B: the MGC803 treated with 50 μg/mL of FMNPs-BRCAA1 for 24 h illustrated up to 45.92% cell were labeled with FMNPs-BRCAA1.Back to article page